X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70) 70
Patent (11) 11
Book / eBook (5) 5
Newspaper Article (5) 5
Book Chapter (4) 4
Dissertation (3) 3
Report (2) 2
Conference Proceeding (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
male (13) 13
female (12) 12
index medicus (12) 12
calculating (11) 11
computing (11) 11
counting (11) 11
physics (11) 11
electric digital data processing (10) 10
adult (8) 8
middle aged (8) 8
efficacy (5) 5
multiple sclerosis (5) 5
multiple sclerosis - drug therapy (5) 5
treatment outcome (5) 5
administration, oral (4) 4
adolescent (4) 4
aged (4) 4
care and treatment (4) 4
child, preschool (4) 4
electric communication technique (4) 4
electricity (4) 4
epidemiology (4) 4
follow-up studies (4) 4
medicine (4) 4
methods (4) 4
patient satisfaction (4) 4
studies (4) 4
usage (4) 4
aged, 80 and over (3) 3
child (3) 3
clinical neurology (3) 3
cloud computing (3) 3
cohort (3) 3
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (3) 3
dermatology (3) 3
double-blind method (3) 3
drug therapy (3) 3
electrical engineering (3) 3
endocrinology & metabolism (3) 3
fingolimod hydrochloride (3) 3
hospitals (3) 3
immunosuppressive agents - therapeutic use (3) 3
it security and ethics (3) 3
medical research (3) 3
medicine, general & internal (3) 3
multiple sclerosis, relapsing-remitting - drug therapy (3) 3
paraganglioma (3) 3
pharmacology & pharmacy (3) 3
research (3) 3
risk factors (3) 3
security and forensic science and technology (3) 3
sphingosine (3) 3
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (3) 3
telephonic communication (3) 3
therapy (3) 3
tolerability (3) 3
tumors (3) 3
age (2) 2
agriculture, multidisciplinary (2) 2
analgesics (2) 2
analysis (2) 2
antifungal agents (2) 2
antifungal agents - administration & dosage (2) 2
antimalarials - pharmacokinetics (2) 2
antimalarials - pharmacology (2) 2
antimalarials - therapeutic use (2) 2
artemether (2) 2
behavior (2) 2
benflumetol (2) 2
causes of (2) 2
cell adhesion & migration (2) 2
chemotherapy (2) 2
children (2) 2
clinical-practice (2) 2
cold metal transfer (2) 2
combined modality therapy (2) 2
cracking (2) 2
data processing (2) 2
diagnosis (2) 2
diclofenac - administration & dosage (2) 2
diclofenac - therapeutic use (2) 2
dilution (2) 2
disease-modifying therapies (2) 2
dose-response relationship, drug (2) 2
drug dosages (2) 2
ethanolamines - pharmacokinetics (2) 2
ethanolamines - pharmacology (2) 2
fluorenes - pharmacokinetics (2) 2
fluorenes - pharmacology (2) 2
folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (2) 2
genetic aspects (2) 2
genotypes (2) 2
growth (2) 2
h13 (2) 2
hardfacing (2) 2
health aspects (2) 2
health sciences (2) 2
heart (2) 2
heart diseases (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 1429 - 22
Journal Article
Drugs, ISSN 0012-6667, 10/2017, Volume 77, Issue 16, pp. 1755 - 1768
Since the approval of fingolimod, several selective sphingosine-1-phosphate receptor modulators have entered clinical development for multiple sclerosis.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | LONG-TERM | BAF312 SIPONIMOD | TUMEFACTIVE MS | ORAL FINGOLIMOD FTY720 | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | OPEN-LABEL | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | DISEASE-MODIFYING THERAPIES | SAFETY PROFILE | CLINICAL-PRACTICE | Fingolimod Hydrochloride - pharmacology | Multiple Sclerosis - diagnosis | Risk Assessment | Humans | Natalizumab - adverse effects | Natalizumab - chemistry | Natalizumab - pharmacology | Fingolimod Hydrochloride - chemistry | Natalizumab - administration & dosage | Multiple Sclerosis - immunology | Immunosuppressive Agents - adverse effects | Receptors, Lysosphingolipid - metabolism | Fingolimod Hydrochloride - adverse effects | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Immunosuppressive Agents - chemistry | Fingolimod Hydrochloride - administration & dosage | Multiple Sclerosis - drug therapy | Multiple sclerosis | Care and treatment | Usage | Dosage and administration | Fingolimod | Drug therapy | Short term | Phosphates | Washouts | Nervous system | Malignancy | Modulators | Sphingosine 1-phosphate | Cell adhesion & migration | Lymphocytes | Phosphate | Risk assessment | Safety | Patient satisfaction | Heart diseases | Drug dosages | Edema | Lymphatic system | Effectiveness | Immunomodulation | Switching | Studies | Heart rate | Side effects | Titration | Review
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 4/2016, Volume 22, Issue 5, pp. 707 - 708
Journal Article
by Okbay, Aysu and Baselmans, B.M.L and Neve, Jan-Emmanuel and Turley, Patrick and Nivard, Michel and Fontana, M.A and Meddens, S.F.W and Linnér, R.K and Rietveld, C.A and Derringer, J and Gratten, Jacob and Lee, James J and Liu, J.Z and Vlaming, Ronald and SAhluwalia, T and Buchwald, J and Cavadino, Alana and Frazier-Wood, Alexis C and Furlotte, N.A and Garfield, V and Geisel, M.H and Gonzalez, Juan R and Haitjema, S and Karlsson, Robert and Der Laan, S.W and Ladwig, Karl-Heinz and Lahti, Jari and Lee, Sven and Lind, Penelope and Liu, T and Matteson, L and Mihailov, Evelin and Miller, Mike and CMinica, C and MNolte, I and Mook-Kanamori, Dennis and Most, Peter and Oldmeadow, Christopher and Qian, Yong and Raitakari, Olli and Rawal, R and Realo, A and Rueedi, R and Schmidt, B and Smith, Albert Vernon and Stergiakouli, Evangelia and Tanaka, Toshiko and Taylor, Kent and Wedenoja, J and Wellmann, J and Westra, Harm-Jan and MWillems, S and Zhao, W and Study, LifeLines Cohort and Amin, Najaf and Bakshi, A and Boyle, Patricia and Cherney, S and Cox, S.R and Davies, Gail and Davis, Oliver S and Ding, Jun and Direk, Nese and Eibich, P and Emeny, Rebecca and Fatemifar, G and Faul, J.D and Ferrucci, Luigi and Forstner, Aneas and Gieger, Christian and Gupta, R and Harris, Tamara B and Harris, Juliette and Holliday, Elizabeth and Hottenga, Jouke Jan and Jager, Philip and Kaakinen, Marika and Kajantie, Eero and Karhunen, V and Kolcic, Ivana and Kumari, Meena and Launer, Lenore and Franke, Lude and Li-Gao, R and Koini, M and Loukola, Anu and Marques-Vidal, P and Montgomery, Grant and Mosing, Miriam and Paternoster, Lavinia and Pattie, Alison and Petrovic, Katja and Pulkki-R'back, L and Quaye, Lydia and R'ikkönen, K and Rudan, Igor and Scott, Rodney and Smith, Jennifer A and Sutin, A.R and Trzaskowski, M and ... and LifeLines Cohort Study
Nature Genetics, ISSN 1061-4036, 06/2016, Volume 48, Issue 6, pp. 624 - 633
Journal Article
Journal of Environmental Quality, ISSN 0047-2425, 2016, Volume 45, Issue 5, pp. 1627 - 1634
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 7/2014, Volume 48, Issue 7, pp. 944 - 944
Journal Article
Journal Article
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, ISSN 1557-170X, 07/2018, Volume 2018, pp. 2024 - 2027
This study described the use of Kernel Least Square Tracker based estimation for 3-dimensional shoulder, elbow motion kinematics from surface Electromyogram... 
Journal Article
PLoS Medicine, ISSN 1549-1277, 06/2018, Volume 15, Issue 6, p. e1002579
Journal Article
JOURNAL OF ENVIRONMENTAL QUALITY, ISSN 0047-2425, 09/2016, Volume 45, Issue 5, pp. 1627 - 1634
The long-term impact of biochar on soil properties and agronomic outcomes is influenced by changes in the physical and chemical properties of biochars that... 
BLACK CARBON | OXIDATION | ENVIRONMENTAL SCIENCES | RETENTION | LABILE | SORPTION | NITROGEN | SOIL | POOLS | RECALCITRANT | SURFACE-CHEMISTRY
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2008, Volume 59, Issue 1, pp. 41 - 54
Journal Article
INDIAN JOURNAL OF CANCER, ISSN 0019-509X, 01/2019, Volume 56, Issue 1, pp. 54 - 58
BACKGROUND: Bladder cancer (BCa) is the ninth most common cancer accounting for 3.9% of all cancer cases as per the Indian Cancer Registry data. There is a... 
muscle invasive bladder cancer | BACILLUS-CALMETTE-GUERIN | ONCOLOGY | survival | RADICAL CYSTECTOMY | GENDER | RISK | 2ND TRANSURETHRAL RESECTION | nonmuscle invasive bladder cancer | Bladder cancer | CARCINOMA
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 2014, Volume 48, Issue 7, pp. 944 - 944
Journal Article